Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × Antilymphocyte Serum × 1 year × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 6 Leukemia, Myeloid, Acute 6 Myelodysplastic Syndromes 5 Lymphoma, Non-Hodgkin 4 Hematologic Neoplasms 4 Myeloproliferative Disorders 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Hodgkin Disease 3 Bone Marrow Failure Disorders 3 Multiple Myeloma 2 Lymphoma, Mantle-Cell 2 Lymphoma, Follicular 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Biphenotypic, Acute 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Shwachman-Diamond Syndrome 1 Sarcoma, Myeloid 1 Rhabdomyosarcoma 1 Recurrence 1 Rasmussen subacute encephalitis 1 Primary Myelofibrosis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Opsoclonus-Myoclonus Syndrome 1 Non-Malignant Neoplasm 1 Neuromyelitis Optica 1 Neurofibrosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Neoplasms, Plasma Cell 1

Interventions

Cyclophosphamide 7 Biopsy 6 romidepsin 5 mogamulizumab 5 fludarabine 5 Brentuximab Vedotin 5 pembrolizumab 4 fludarabine phosphate 4 Specimen Handling 4 Magnetic Resonance Spectroscopy 4 Immunoglobulin G 4 Disulfides 4 ruxolitinib 3 Peripheral Blood Stem Cell Transplantation 3 Nivolumab 3 Mycophenolic Acid 3 Lenalidomide 3 Depsipeptides 3 hypericin 2 belinostat 2 Whole-Body Irradiation 2 Tacrolimus 2 Melphalan 2 Lactones 2 Etoposide 2 Busulfan 2 Bexarotene 2 trastuzumab biosimilar HLX02 1 tofacitinib 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡